ASST Grande Ospedale Metropolitano Niguarda
ASST Grande Ospedale Metropolitano Niguarda
Milan, Italy29 results · Page 1 of 2
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Pulmonary Complications Following TEVAR | Acute Aortic Syndrome, Aneurysm, Aortic Dissection, Dissection, Blood Vessel, aortic disorder, cardiovascular disorder, vascular disorder | Active, not recruiting | Not stated | 2026-10-07 | NCT07863453 | |
| A Study Observing Everyday Effectiveness and Safety of the Drug Elafibranor in Participants With Primary Biliary Cholangitis Who Are Receiving Ongoing Treatment | Digestive System Diseases, Fibrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, bile duct disorder, biliary tract disorder, cholestasis, cirrhosis of liver, intrahepatic cholestasis, liver disorder, primary biliary cholangitis | Active, not recruiting | Not stated | 2026-10-01 | NCT06447168 | |
| A Trial That Compare Two Treatments in Newly Diagnosed Myeloma Patients Not Eligible for Transplant | Blood Protein Disorders, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, cardiovascular disorder, hematologic disorder, hemorrhagic disease, immune system disorder, immunoproliferative disorder, lymphoproliferative syndrome, monoclonal gammopathy, neoplasm, plasma cell neoplasm, vascular disorder, vascular hemostatic disease | Active, not recruiting | Phase 3 | 2026-09-21 | NCT04096066 | |
| A Non-interventional Study of Participants With BPDCN Treated With Chemotherapy | CD4+/CD56+ hematodermic neoplasm, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Neoplasms by Site, Skin and Connective Tissue Diseases, hematologic disorder, hematopoietic and lymphoid system neoplasm, leukemia, lymphoma, malignant histiocytosis, neoplasm, skin disorder, skin neoplasm | Recruiting | Not stated | 2026-09-15 | NCT07785180 | |
| ROMANCE: "Irinotecan Plus Cetuximab Rechallenge Versus Trifluridine/Tipiracil Plus Bevacizumab in Molecularly Selected Metastatic Colorectal Cancer" | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, colonic disorder, colorectal neoplasm, digestive system disorder, digestive system neoplasm, intestinal disorder, neoplasm, rectal disorder | Recruiting | Phase 2 | 2026-09-11 | NCT07381764 | |
| ENVISION IDE Trial: Safety and Effectiveness of NAVITOR in Transcatheter Aortic Valve Implantation | Ventricular Outflow Obstruction, aortic valve disorder, aortic valve stenosis, cardiovascular disorder, heart disorder, heart valve disorder | Enrolling by invitation | Not applicable | 2026-09-11 | NCT05932615 | |
| 177Lu-PSMA-I&T for Metastatic Castration-Resistant Prostate Cancer | Genital Diseases, Male Urogenital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, male reproductive organ cancer, male reproductive system disorder, neoplasm, prostate cancer, prostate disorder | Active, not recruiting | Phase 3 | 2026-09-04 | NCT05204927 | |
| Endoscopic Management of Biliopancreatic Disease in the Lombardy Pancreas Units | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, endocrine system disorder, malignant endocrine neoplasm, malignant pancreatic neoplasm, neoplasm, pancreas disorder, pancreatic neoplasm | Not yet recruiting | Not stated | 2026-09-03 | NCT07418164 | |
| NATURE (EnVast as an Adjunct PPCI in Subjects Presenting With STEMI) | Segment Elevation Myocardial Infarction (STEMI) | Active, not recruiting | Not applicable | 2026-08-19 | NCT04969471 | |
| Paclitaxel, Ramucirumab and Tislelizumab Switch Maintenance in Advanced HER2-negative and PD-L1 TAP Score of 5 or More Advanced Gastroesophageal Adenocarcinoma | gastroesophageal adenocarcinoma | Not yet recruiting | Phase 3 | 2026-08-18 | NCT07763171 | |
| Development of a Natural Language Processing Tool to Enable Clinical Research in Emergency Medicine | Emergency Medicine | Recruiting | Not stated | 2026-07-15 | NCT06240572 | |
| Cera™ Vascular Plug System Post-Market Clinical Follow-Up | Aneurysm, Cardiovascular Abnormalities, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, Endoleak, Fistula, Hemorrhage, Pathologic Processes, Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms, Postoperative Complications, Postoperative Hemorrhage, Pulmonary Arteriovenous Fistulas, Vascular Fistula, arteriovenous hemangioma/malformation, cardiovascular disorder, congenital arteriovenous fistula, liver disorder, portal hypertension, vascular disorder, vascular malformation | Recruiting | Not stated | 2026-06-12 | NCT06099015 | |
| RandomIsed sTudy of Physiologic cArdiac stimuLation in patIents With Atrio-ventricular Conduction Disease | Arrhythmias, Cardiac, Cardiac Conduction System Disease, Pathologic Processes, Pathological Conditions, Signs and Symptoms, atrioventricular block, atrioventricular dissociation, cardiovascular disorder, heart disorder | Recruiting | Not applicable | 2026-05-27 | NCT07279870 | |
| A Study of CYP-001 in Combination With Corticosteroids in Adults With High-risk aGvHD | acute graft versus host disease, graft versus host disease, immune system disorder | Active, not recruiting | Phase 2 | 2026-05-26 | NCT05643638 | |
| A Study to Learn How Safe and How Well Linvoseltamab Works Compared to Standard Treatment in Adult Patients With Multiple Myeloma Who Are Not Eligible for Transplant | Blood Protein Disorders, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, cardiovascular disorder, hematologic disorder, hemorrhagic disease, immune system disorder, immunoproliferative disorder, lymphoproliferative syndrome, monoclonal gammopathy, neoplasm, plasma cell neoplasm, vascular disorder, vascular hemostatic disease | Recruiting | Phase 3 | 2026-03-25 | NCT06932562 | |
| Sirolimus-coated Balloon Versus Drug-eluting Stent in Native Coronary Vessels - TRANSFORM II | Arterial Occlusive Diseases, arteriosclerosis disorder, cardiovascular disorder, coronary artery disorder, coronary stenosis, heart disorder, myocardial ischemia, vascular disorder | Active, not recruiting | Not applicable | 2026-02-19 | NCT04893291 | |
| Study of SGR-1505 in Mature B-Cell Neoplasms | ALK-positive large B-cell lymphoma, B-cell chronic lymphocytic leukemia, B-cell neoplasm, Blood Protein Disorders, Burkitt lymphoma, Chronic Disease, DNA Virus Infections, Digestive System Diseases, Disease Attributes, Epstein-Barr virus infection, Hemic and Lymphatic Diseases, Herpesviridae infectious disease, Infections, Leukemia, B-Cell, Lymphoma, B-Cell, Marginal Zone, Neoplasms by Histologic Type, Pathologic Processes, Pathological Conditions, Signs and Symptoms, T-cell/histiocyte rich large B cell lymphoma, Tumor Virus Infections, Waldenstrom macroglobulinemia, cardiovascular disorder, diffuse large B-cell lymphoma, digestive system disorder, follicular lymphoma, hematologic disorder, hemorrhagic disease, high grade B-cell lymphoma, hypertrophic pyloric stenosis, immune system disorder, immunoproliferative disorder, leukemia, lymphatic system disorder, lymphoid leukemia, lymphoma, lymphoplasmacytic lymphoma, lymphoproliferative syndrome, mantle cell lymphoma, monoclonal gammopathy, neoplasm, neoplasm of mature B-cells, nodal marginal zone B-cell lymphoma, non-Hodgkin lymphoma, plasma cell neoplasm, plasmablastic lymphoma, primary cutaneous follicle center lymphoma, primary effusion lymphoma, pyloric stenosis, splenic marginal zone lymphoma, stomach disorder, vascular disorder, vascular hemostatic disease, viral infectious disease | Recruiting | Phase 1 | 2026-02-13 | NCT05544019 | |
| Continuation of Cetuximab Beyond First-Line Progression in Metastatic Colorectal Cancer | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, colonic disorder, colorectal neoplasm, digestive system disorder, digestive system neoplasm, intestinal disorder, neoplasm, rectal disorder | Recruiting | Phase 3 | 2026-02-05 | NCT07389265 | |
| Landiolol in Mitral Valve Surgery | Cardiac Output, Low, Low Cardiac Output Syndrome, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, cardiovascular disorder, heart disorder, heart failure | Recruiting | Phase 4 | 2025-12-29 | NCT06793670 | |
| Phase II Study of Radiotherapy Followed by Durvalumab and Ceralasertib in Stage III NSCLC Patients With Thoracic Relapses +/- Oligometastases After PACIFIC Regimen | Non Small Cell Lung Cancer NSCLC | Recruiting | Phase 2 | 2025-12-18 | NCT06680050 | |
| Post Authorization Efficacy and Safety Study (PAES) to Confirm and Collect More Clinical Data of Buccalin® Tablets In the Prophylaxis of Recurrent Lower Respiratory Tract Infections (RLRTIs). | Infections, respiratory system disorder, respiratory tract infectious disorder | Recruiting | Phase 4 | 2025-12-10 | NCT06736288 | |
| Phase 3, Double-blind, Randomized, Placebo-controlled Trial to Evaluate the Efficacy and Safety of AR1001 in Participants With Early Alzheimer's Disease (Polaris-AD) | Alzheimer disease, brain disorder, central nervous system disorder, cognitive disorder, dementia, nervous system disorder, neurodegenerative disease, psychiatric disorder, tauopathy | Active, not recruiting | Phase 3 | 2025-10-02 | NCT05531526 | |
| MYTHS - MYocarditis THerapy With Steroids | cardiomyopathy, cardiovascular disorder, heart disorder, myocarditis | Recruiting | Phase 3 | 2025-07-31 | NCT05150704 | |
| Vagal Nerve Stimulation to Treat Disorders of Consciousness | Coma, Consciousness Disorders, Neurobehavioral Manifestations, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Unconsciousness, cognitive disorder, nervous system disorder, psychiatric disorder | Not yet recruiting | Not applicable | 2025-07-22 | NCT07077135 | |
| Pilot Italian Cardiogenic Shock Initiative | Infarction, Necrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Shock, Shock, Cardiogenic, cardiovascular disorder, heart disorder, ischemic disease, myocardial infarction, myocardial ischemia, vascular disorder | Recruiting | Not stated | 2025-07-01 | NCT06475456 |